Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation. Fair value range: low $172, high $303, with mid-point at $237.
Key risk is a return to undisciplined M&A or high SBC dilution.
Fair value
$237
Margin of safety
+23.3%
Confidence
88/100
Moat
9/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$181.82Price
Low $171.93
Mid $236.95
High $303.18
Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation.
High switching costs within core
High switching costs within core enterprise ecosystem
Deep integration of multi-cloud CRM
Deep integration of multi-cloud CRM software
Cycle upside
AI-driven product cycles reignite enterprise IT software spending.
Our financial-history view of CRM (CRM) covers revenue, gross profit, operating income, and net income across the past five fiscal years, with year-over-year growth and margin context for each line.
The revenue trajectory is reported in the financial-history section with year-over-year growth rates. Direction and acceleration are summarised inline; the full table sits within the parent financials tab.
We track operating income alongside operating margin so the reader can separate top-line growth from operating leverage. The numbers analysis subsection flags one-offs, restructuring, and stock-based-compensation effects when material.
Net income is shown together with EPS so dilution and buybacks are visible alongside profit. Where reported net income diverges materially from operating cash flow, the discrepancy is called out in the numbers-analysis subsection.
FAQ
CRM — frequently asked questions
Based on our latest analysis, CRM looks meaningfully undervalued. The current price is $182 versus a composite fair-value midpoint of $237 (range $172–$303), which implies roughly 30.3% upside to the midpoint.
Our composite fair-value range for CRM is $172–$303, with a midpoint of $237. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for CRM's archetype.
Our current rating for CRM is Strong Buy with a confidence score of 88/100. Strong Buy. The market over-penalizes top-line deceleration while under-appreciating the structural pivot toward margin expansion, massive free cash flow conversion, and aggressive share repurchases. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for CRM are: Growth Stagnation; M&A Relapse; AI Displacement. The single biggest risk is Growth Stagnation: Core software markets saturate entirely, permanently capping top-line growth below 5%.
Our current rating for CRM is Strong Buy, issued with a confidence score of 88/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($172–$303) versus the current price of $182.
CRM is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for CRM.